社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
WengYongLi
Wander beyond the wilderness
IP属地:未知
+关注
帖子 · 175
帖子 · 175
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
WengYongLi
WengYongLi
·
2021-12-24
Pfizer will continue to soar short term. There are so little competition for vaccines.
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
看
1,463
回复
1
点赞
1
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-12-15
Very insightful especially on crypto’s topic.
3 Things About Nvidia That Smart Investors Know
Nvidia is firing on all cylinders, but investors should recognize its three hidden weaknesses.
3 Things About Nvidia That Smart Investors Know
看
1,608
回复
1
点赞
1
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-12-11
Its more than what meets the headlines. China is always cautious. But good for long run
非常抱歉,此主贴已删除
看
1,939
回复
1
点赞
3
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-11-17
Who cares what bofa says. They only care about their own bags
Sea shares fell more than 7% in morning trading
Sea shares fell more than 7% after cut to Neutral at BofA on slowing growth. Bank of America analys
Sea shares fell more than 7% in morning trading
看
1,723
回复
评论
点赞
4
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-11-12
Slow but sure
看
1,810
回复
评论
点赞
4
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-11-10
As long as they filed sec, its not illegal. Honestly, they also think tesla is overvalued
非常抱歉,此主贴已删除
看
2,007
回复
1
点赞
7
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-11-09
$Iveda Solutions, Inc.(IVDA)$
Up only
看
1,578
回复
评论
点赞
1
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-11-07
$Booking Holdings(BKNG)$
This has been on meteoric rise. Once gantry all open, price goes up another 30%
看
1,649
回复
评论
点赞
3
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-11-03
$Iveda Solutions, Inc.(IVDA)$
slow and sure
看
1,854
回复
评论
点赞
3
编组 21备份 2
分享
举报
WengYongLi
WengYongLi
·
2021-10-20
$4DS Memory(4DS.AU)$
Hidden and suspended
看
1,600
回复
评论
点赞
3
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3574715322913604","uuid":"3574715322913604","gmtCreate":1611622781309,"gmtModify":1628260964620,"name":"WengYongLi","pinyin":"wengyongli","introduction":"","introductionEn":"","signature":"Wander beyond the wilderness","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":26,"headSize":134,"tweetSize":175,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.15","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.24","exceedPercentage":"80.60%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":8,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":698360236,"gmtCreate":1640306326685,"gmtModify":1640306391646,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"Pfizer will continue to soar short term. There are so little competition for vaccines. ","listText":"Pfizer will continue to soar short term. There are so little competition for vaccines. ","text":"Pfizer will continue to soar short term. There are so little competition for vaccines.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698360236","repostId":"1172289344","repostType":4,"repost":{"id":"1172289344","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1640302012,"share":"https://ttm.financial/m/news/1172289344?lang=&edition=full","pubTime":"2021-12-24 07:26","market":"us","language":"en","title":"How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?","url":"https://stock-news.laohu8.com/highlight/detail?id=1172289344","media":"Benzinga","summary":"Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for","content":"<p><b>Pfizer, Inc.</b> announced Wednesday its oral COVID-19 antiviral pill, <b>Paxlovid,</b> has been authorized for use by the U.S. Food and Drug Administration.</p>\n<p><b>The Pfizer Analysts:</b>SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer.</p>\n<p>BofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target.</p>\n<p><b>Broad Label, Increased Supply To Give Pfizer Dominant Market Position:</b>Pfizer received the nod for the oral COVID-19 treatment ahead of <b>Merck & Co., Inc.</b>, which submitted its application for itsmolnupiravirmore than a month ahead of Pfizer, Porges said in a note.</p>\n<p>The analyst sees the increase in Pfizer's expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink's current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said.</p>\n<p>Revenue contribution will drop to $10 billion in 2024, the analyst said. This total $67 billion in Paxlovid sales estimated for 2022-'24 is well above consensus, he added.</p>\n<p>The impact of drug-drug interactions on Paxlovid uptake will be modest since many of the drugs on the list can be paused for the short duration of Paxlovid treatment without significant impact for patients, Porges said. Patients that will likely be excluded from Paxlovid use are those with severe liver or renal impairment and those who have uncontrolled HIV-1 infection, he added.</p>\n<p>The drug label also didn't preclude pregnant women from Paxlovid treatment and painted a risk/benefit profile that was relatively benign compared to Merck's molnupiravir, which showed embryonic development and fetal growth risks in animals, the analyst said.</p>\n<p>Paxlovid has a better efficacy profile than some leading antibody therapies, and with some of the antibody therapies having lost efficacy against the omicron variant, Paxlovid will be a \"highly attractive option for physicians and patients,\" Porges said.</p>\n<p><b>Paxlovid Should Remain A Steady Contributor, BofA Says:</b>There should be no problem selling every course of Paxlovid Pfizer makes in 2022, BofA analyst Meacham said. The lag time between production and shipping/revenue recognition means Pfizer won't recognize the revenue from every dose in 2022, he added.</p>\n<p>Longer-term, Paxlovid is likely to remain a steady contributor, the analyst said.</p>\n<p>\"We expect breakthrough infections to continue regularly in the endemic phase, and while a baseline level of immunity from vaccines and prior infections will limit severity, we expect treatment of COVID cases as they occur in high-risk individuals to be standard of care,\" Meacham said.</p>\n<p>Government entities are expected to stockpile Merck's pill and so initial sales will likely be there, the analyst said. Longer-term, Paxlovid will likely be the preferred agent, he added.</p>\n<p><b>Pfizer Price Action:</b> Pfizer shares closed lower 1.41% to $58.71 on Thursday.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-24 07:26</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Pfizer, Inc.</b> announced Wednesday its oral COVID-19 antiviral pill, <b>Paxlovid,</b> has been authorized for use by the U.S. Food and Drug Administration.</p>\n<p><b>The Pfizer Analysts:</b>SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer.</p>\n<p>BofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target.</p>\n<p><b>Broad Label, Increased Supply To Give Pfizer Dominant Market Position:</b>Pfizer received the nod for the oral COVID-19 treatment ahead of <b>Merck & Co., Inc.</b>, which submitted its application for itsmolnupiravirmore than a month ahead of Pfizer, Porges said in a note.</p>\n<p>The analyst sees the increase in Pfizer's expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink's current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said.</p>\n<p>Revenue contribution will drop to $10 billion in 2024, the analyst said. This total $67 billion in Paxlovid sales estimated for 2022-'24 is well above consensus, he added.</p>\n<p>The impact of drug-drug interactions on Paxlovid uptake will be modest since many of the drugs on the list can be paused for the short duration of Paxlovid treatment without significant impact for patients, Porges said. Patients that will likely be excluded from Paxlovid use are those with severe liver or renal impairment and those who have uncontrolled HIV-1 infection, he added.</p>\n<p>The drug label also didn't preclude pregnant women from Paxlovid treatment and painted a risk/benefit profile that was relatively benign compared to Merck's molnupiravir, which showed embryonic development and fetal growth risks in animals, the analyst said.</p>\n<p>Paxlovid has a better efficacy profile than some leading antibody therapies, and with some of the antibody therapies having lost efficacy against the omicron variant, Paxlovid will be a \"highly attractive option for physicians and patients,\" Porges said.</p>\n<p><b>Paxlovid Should Remain A Steady Contributor, BofA Says:</b>There should be no problem selling every course of Paxlovid Pfizer makes in 2022, BofA analyst Meacham said. The lag time between production and shipping/revenue recognition means Pfizer won't recognize the revenue from every dose in 2022, he added.</p>\n<p>Longer-term, Paxlovid is likely to remain a steady contributor, the analyst said.</p>\n<p>\"We expect breakthrough infections to continue regularly in the endemic phase, and while a baseline level of immunity from vaccines and prior infections will limit severity, we expect treatment of COVID cases as they occur in high-risk individuals to be standard of care,\" Meacham said.</p>\n<p>Government entities are expected to stockpile Merck's pill and so initial sales will likely be there, the analyst said. Longer-term, Paxlovid will likely be the preferred agent, he added.</p>\n<p><b>Pfizer Price Action:</b> Pfizer shares closed lower 1.41% to $58.71 on Thursday.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172289344","content_text":"Pfizer, Inc. announced Wednesday its oral COVID-19 antiviral pill, Paxlovid, has been authorized for use by the U.S. Food and Drug Administration.\nThe Pfizer Analysts:SVB Leerink analyst Geoffrey Porges has a Market Perform rating and a $52 price target for Pfizer.\nBofA Securities analyst Geoff Meacham maintained a Neutral rating and a $59 price target.\nBroad Label, Increased Supply To Give Pfizer Dominant Market Position:Pfizer received the nod for the oral COVID-19 treatment ahead of Merck & Co., Inc., which submitted its application for itsmolnupiravirmore than a month ahead of Pfizer, Porges said in a note.\nThe analyst sees the increase in Pfizer's expected supply of Paxlovid to 120 million courses next year as significant. The company will sell and distribute most of these courses, resulting in revenue well in excess of SVB Leerink's current forecast of $24 billion in Paxlovid sales in 2022 and $33 billion in 2023, the analyst said.\nRevenue contribution will drop to $10 billion in 2024, the analyst said. This total $67 billion in Paxlovid sales estimated for 2022-'24 is well above consensus, he added.\nThe impact of drug-drug interactions on Paxlovid uptake will be modest since many of the drugs on the list can be paused for the short duration of Paxlovid treatment without significant impact for patients, Porges said. Patients that will likely be excluded from Paxlovid use are those with severe liver or renal impairment and those who have uncontrolled HIV-1 infection, he added.\nThe drug label also didn't preclude pregnant women from Paxlovid treatment and painted a risk/benefit profile that was relatively benign compared to Merck's molnupiravir, which showed embryonic development and fetal growth risks in animals, the analyst said.\nPaxlovid has a better efficacy profile than some leading antibody therapies, and with some of the antibody therapies having lost efficacy against the omicron variant, Paxlovid will be a \"highly attractive option for physicians and patients,\" Porges said.\nPaxlovid Should Remain A Steady Contributor, BofA Says:There should be no problem selling every course of Paxlovid Pfizer makes in 2022, BofA analyst Meacham said. The lag time between production and shipping/revenue recognition means Pfizer won't recognize the revenue from every dose in 2022, he added.\nLonger-term, Paxlovid is likely to remain a steady contributor, the analyst said.\n\"We expect breakthrough infections to continue regularly in the endemic phase, and while a baseline level of immunity from vaccines and prior infections will limit severity, we expect treatment of COVID cases as they occur in high-risk individuals to be standard of care,\" Meacham said.\nGovernment entities are expected to stockpile Merck's pill and so initial sales will likely be there, the analyst said. Longer-term, Paxlovid will likely be the preferred agent, he added.\nPfizer Price Action: Pfizer shares closed lower 1.41% to $58.71 on Thursday.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607706537,"gmtCreate":1639583446503,"gmtModify":1639583446829,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"Very insightful especially on crypto’s topic. ","listText":"Very insightful especially on crypto’s topic. ","text":"Very insightful especially on crypto’s topic.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607706537","repostId":"2191956629","repostType":4,"repost":{"id":"2191956629","kind":"highlight","pubTimestamp":1639581203,"share":"https://ttm.financial/m/news/2191956629?lang=&edition=full","pubTime":"2021-12-15 23:13","market":"us","language":"en","title":"3 Things About Nvidia That Smart Investors Know","url":"https://stock-news.laohu8.com/highlight/detail?id=2191956629","media":"Motley Fool","summary":"Nvidia is firing on all cylinders, but investors should recognize its three hidden weaknesses.","content":"<p>Most investors likely recognize <b>Nvidia</b> (NASDAQ:NVDA) as the world's largest producer of discrete GPUs. They'll also attribute its recent growth spurt to the secular expansion of the PC gaming and data center markets, and point out that it's trying to buy Arm Holdings -- the world's largest designer of mobile chips -- from <b>SoftBank</b> (OTC:SFTB.Y) for $40 billion.</p>\n<p>However, those bullet points only scratch the surface of Nvidia's business. To gain a deeper understanding of this complex chipmaker, we should analyze three finer points that only smarter investors have likely spotted.</p>\n<h2>1. It faces a hidden competitor in the data center market</h2>\n<p>The bullish thesis for Nvidia in the data center market is easy to grasp. CPUs use scalar processing, which process one piece of data at a time, while GPUs use vector processing, which processes a wide range of integers and floating point numbers simultaneously.</p>\n<p>CPUs can't process machine learning and artificial intelligence (AI) tasks as efficiently as GPUs, so big data center operators have been installing more of Nvidia's GPUs to handle those tasks. That's why Nvidia's data center revenue rose 55% year-over-year last quarter and accounted for 41% of its top line.</p>\n<p>But Nvidia faces a hidden competitor in this high-growth market: Graphcore, a private U.K. chipmaker that develops IPUs (intelligence processing units) for data centers. IPUs use graph processing, which process all of the data mapped out on a single graph at once.</p>\n<p>Graphcore claims graph processing is more efficient than both scalar and vector processing. Last year, it released the M2000, a plug-and-play AI processing system that directly competes against Nvidia's A100 system. At the time of its launch, the M2000 delivered one petaflop of processing power for $32,450, compared to the A100's price of $39,800 per petaflop.</p>\n<p>That price gap highlights a hidden long-term risk to Nvidia, since big data centers require thousands of petaflops of processing power. Nvidia is still much larger and more well-known than Graphcore, but the development of IPUs could challenge the notion that GPUs are the best choice for AI tasks.</p>\n<h2>2. It's not the world's largest GPU maker</h2>\n<p>Nvidia controlled 83% of the discrete GPU market in the third quarter of 2021, according to JPR. <b><a href=\"https://laohu8.com/S/AMD\">AMD</a></b> (NASDAQ:AMD) held the remaining 17%.</p>\n<p>Yet<b> Intel</b> (NASDAQ:INTC) is actually the world's largest GPU maker thanks to its integrated graphics chips for lower-end desktops and laptops. If we factor in those chips, Intel controlled 62% of the global GPU market in the third quarter, according to JPR, compared to 20% for Nvidia and 18% for AMD.</p>\n<p>That difference wouldn't be worth mentioning if Intel and Nvidia were staying in their own lanes. After all, Intel seemingly abandoned the discrete GPU market more than two decades ago.</p>\n<p>But in 2018, Intel announced it would launch a new discrete GPU by 2020. It achieved that goal with the launch of its new Xe GPUs last summer.</p>\n<p>The first chips in that series, the Iris Xe Max (DG1), targets Nvidia's GeForce MX and AMD's Radeon RX chips in gaming notebooks. Intel plans to target the desktop market with its higher-end DG2 chips next year, and it's developing an even higher-end GPU (codenamed Ponte Vecchio) to challenge Nvidia's high-end GPUs in the data center market.</p>\n<p>Intel hasn't emerged as a major threat yet, but that situation could change as it bundles more of its GPUs with CPUs for OEMs. Nvidia's investors should closely monitor these developments and see if they'll impact the gaming business, which generated 45% of its revenue last quarter.</p>\n<h2>3. The cryptocurrency market is a double-edged sword</h2>\n<p>Lastly, investors should pay attention to the cryptocurrency market. The last cryptocurrency boom and bust cycle in 2018 caused major headaches for Nvidia as miners hoarded cards and drove up prices for gamers. After that bubble popped, those miners flooded the secondhand market with used cards, which reduced the appeal of Nvidia's newer GPUs.</p>\n<p>Nvidia has taken two major steps to avoid another bubble: It capped the hash rate of its new RTX GPUs to make them less appealing for <b>Ethereum </b>(CRYPTO:ETH) miners, and released a new line of dedicated crypto mining (CMP) cards to keep its gaming and mining markets separate.</p>\n<p>Unfortunately, hackers quickly found a way to bypass Nvidia's hash rate limitations for its RTX cards. Meanwhile, the hot crypto market has recently caused prices for Nvidia's CMP cards to skyrocket, and that trend could make unlocked RTX cards a more cost efficient way to mine Ethereum.</p>\n<p>That's the exact scenario Nvidia wanted to avoid, and it could face another ugly boom and bust in the cryptocurrency market in the near future.</p>\n<h2>Will these factors weigh down Nvidia's stock?</h2>\n<p>I'm still bullish on Nvidia and its long-term growth potential in the gaming and data center markets. But smart investors shouldn't ignore these three hidden threats, which could all stir up unexpected headwinds and challenge analysts' rising expectations for the beloved chipmaker.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Things About Nvidia That Smart Investors Know</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Things About Nvidia That Smart Investors Know\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-15 23:13 GMT+8 <a href=https://www.fool.com/investing/2021/12/15/3-things-about-nvidia-that-smart-investors-know/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Most investors likely recognize Nvidia (NASDAQ:NVDA) as the world's largest producer of discrete GPUs. They'll also attribute its recent growth spurt to the secular expansion of the PC gaming and data...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/15/3-things-about-nvidia-that-smart-investors-know/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4211":"区域性银行","BK4549":"软银资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4550":"红杉资本持仓","ISBC":"投资者银行","BK4567":"ESG概念","BK4551":"寇图资本持仓","BK4548":"巴美列捷福持仓","BK4141":"半导体产品","BK4534":"瑞士信贷持仓","NVDA":"英伟达","BK4554":"元宇宙及AR概念","BK4543":"AI","BK4532":"文艺复兴科技持仓","BK4503":"景林资产持仓","BK4529":"IDC概念","BK4527":"明星科技股"},"source_url":"https://www.fool.com/investing/2021/12/15/3-things-about-nvidia-that-smart-investors-know/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2191956629","content_text":"Most investors likely recognize Nvidia (NASDAQ:NVDA) as the world's largest producer of discrete GPUs. They'll also attribute its recent growth spurt to the secular expansion of the PC gaming and data center markets, and point out that it's trying to buy Arm Holdings -- the world's largest designer of mobile chips -- from SoftBank (OTC:SFTB.Y) for $40 billion.\nHowever, those bullet points only scratch the surface of Nvidia's business. To gain a deeper understanding of this complex chipmaker, we should analyze three finer points that only smarter investors have likely spotted.\n1. It faces a hidden competitor in the data center market\nThe bullish thesis for Nvidia in the data center market is easy to grasp. CPUs use scalar processing, which process one piece of data at a time, while GPUs use vector processing, which processes a wide range of integers and floating point numbers simultaneously.\nCPUs can't process machine learning and artificial intelligence (AI) tasks as efficiently as GPUs, so big data center operators have been installing more of Nvidia's GPUs to handle those tasks. That's why Nvidia's data center revenue rose 55% year-over-year last quarter and accounted for 41% of its top line.\nBut Nvidia faces a hidden competitor in this high-growth market: Graphcore, a private U.K. chipmaker that develops IPUs (intelligence processing units) for data centers. IPUs use graph processing, which process all of the data mapped out on a single graph at once.\nGraphcore claims graph processing is more efficient than both scalar and vector processing. Last year, it released the M2000, a plug-and-play AI processing system that directly competes against Nvidia's A100 system. At the time of its launch, the M2000 delivered one petaflop of processing power for $32,450, compared to the A100's price of $39,800 per petaflop.\nThat price gap highlights a hidden long-term risk to Nvidia, since big data centers require thousands of petaflops of processing power. Nvidia is still much larger and more well-known than Graphcore, but the development of IPUs could challenge the notion that GPUs are the best choice for AI tasks.\n2. It's not the world's largest GPU maker\nNvidia controlled 83% of the discrete GPU market in the third quarter of 2021, according to JPR. AMD (NASDAQ:AMD) held the remaining 17%.\nYet Intel (NASDAQ:INTC) is actually the world's largest GPU maker thanks to its integrated graphics chips for lower-end desktops and laptops. If we factor in those chips, Intel controlled 62% of the global GPU market in the third quarter, according to JPR, compared to 20% for Nvidia and 18% for AMD.\nThat difference wouldn't be worth mentioning if Intel and Nvidia were staying in their own lanes. After all, Intel seemingly abandoned the discrete GPU market more than two decades ago.\nBut in 2018, Intel announced it would launch a new discrete GPU by 2020. It achieved that goal with the launch of its new Xe GPUs last summer.\nThe first chips in that series, the Iris Xe Max (DG1), targets Nvidia's GeForce MX and AMD's Radeon RX chips in gaming notebooks. Intel plans to target the desktop market with its higher-end DG2 chips next year, and it's developing an even higher-end GPU (codenamed Ponte Vecchio) to challenge Nvidia's high-end GPUs in the data center market.\nIntel hasn't emerged as a major threat yet, but that situation could change as it bundles more of its GPUs with CPUs for OEMs. Nvidia's investors should closely monitor these developments and see if they'll impact the gaming business, which generated 45% of its revenue last quarter.\n3. The cryptocurrency market is a double-edged sword\nLastly, investors should pay attention to the cryptocurrency market. The last cryptocurrency boom and bust cycle in 2018 caused major headaches for Nvidia as miners hoarded cards and drove up prices for gamers. After that bubble popped, those miners flooded the secondhand market with used cards, which reduced the appeal of Nvidia's newer GPUs.\nNvidia has taken two major steps to avoid another bubble: It capped the hash rate of its new RTX GPUs to make them less appealing for Ethereum (CRYPTO:ETH) miners, and released a new line of dedicated crypto mining (CMP) cards to keep its gaming and mining markets separate.\nUnfortunately, hackers quickly found a way to bypass Nvidia's hash rate limitations for its RTX cards. Meanwhile, the hot crypto market has recently caused prices for Nvidia's CMP cards to skyrocket, and that trend could make unlocked RTX cards a more cost efficient way to mine Ethereum.\nThat's the exact scenario Nvidia wanted to avoid, and it could face another ugly boom and bust in the cryptocurrency market in the near future.\nWill these factors weigh down Nvidia's stock?\nI'm still bullish on Nvidia and its long-term growth potential in the gaming and data center markets. But smart investors shouldn't ignore these three hidden threats, which could all stir up unexpected headwinds and challenge analysts' rising expectations for the beloved chipmaker.","news_type":1,"symbols_score_info":{"ISBC":0.9,"NVDA":0.9}},"isVote":1,"tweetType":1,"viewCount":1608,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605510379,"gmtCreate":1639189290601,"gmtModify":1639189434109,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"Its more than what meets the headlines. China is always cautious. But good for long run","listText":"Its more than what meets the headlines. China is always cautious. But good for long run","text":"Its more than what meets the headlines. China is always cautious. But good for long run","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/605510379","repostId":"2190275356","repostType":4,"isVote":1,"tweetType":1,"viewCount":1939,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878809285,"gmtCreate":1637162516571,"gmtModify":1637162516688,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"Who cares what bofa says. They only care about their own bags","listText":"Who cares what bofa says. They only care about their own bags","text":"Who cares what bofa says. They only care about their own bags","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878809285","repostId":"1191602151","repostType":4,"repost":{"id":"1191602151","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637160729,"share":"https://ttm.financial/m/news/1191602151?lang=&edition=full","pubTime":"2021-11-17 22:52","market":"us","language":"en","title":"Sea shares fell more than 7% in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1191602151","media":"Tiger Newspress","summary":"Sea shares fell more than 7% after cut to Neutral at BofA on slowing growth.\n\nBank of America analys","content":"<p>Sea shares fell more than 7% after cut to Neutral at BofA on slowing growth.</p>\n<p><img src=\"https://static.tigerbbs.com/4b220c8739f206a6f035287f0bc93429\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank of America analyst Sachin Salgaonkar downgrades the stock to a Neutral rating from a Buy.</p>\n<p>In addition, Sea kept gaming guidance unchanged, which implies slowing growth in Q4, Salgaonkar writes in a note to clients.</p>\n<p>The analyst sees a balanced risk/reward for the stock; shares climb 85% Y/Y.</p>\n<p>\"We cut our gaming revenue estimates to factor in a slowdown and increase e-com losses as we factor increasing cash-burn,\" the analyst notes.</p>\n<p>Lowers full-year 2022 loss per share estimate to $5.72 and 2023 to $4.45 per share.</p>\n<p>\"Consensus is yet to factor in rising losses in the medium term based on expansion into new markets in Europe/India.\"</p>\n<p>The Neutral rating agrees theNeutral Quant Rating, with the best factor grade in Momentum and the worst in Valuation.</p>\n<p>However, the Neutral rating diverges from the Very BullishWall Street Analyst Rating(18 Very Bullish, 7 Bullish).</p>\n<p>Previously, (June 10) Sea gotupgraded to Buy at BofA.</p>\n<p><img src=\"https://static.tigerbbs.com/6013b61a037fd78ec0a89cb8d3193ddc\" tg-width=\"726\" tg-height=\"279\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sea shares fell more than 7% in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSea shares fell more than 7% in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-17 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sea shares fell more than 7% after cut to Neutral at BofA on slowing growth.</p>\n<p><img src=\"https://static.tigerbbs.com/4b220c8739f206a6f035287f0bc93429\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n<p>Bank of America analyst Sachin Salgaonkar downgrades the stock to a Neutral rating from a Buy.</p>\n<p>In addition, Sea kept gaming guidance unchanged, which implies slowing growth in Q4, Salgaonkar writes in a note to clients.</p>\n<p>The analyst sees a balanced risk/reward for the stock; shares climb 85% Y/Y.</p>\n<p>\"We cut our gaming revenue estimates to factor in a slowdown and increase e-com losses as we factor increasing cash-burn,\" the analyst notes.</p>\n<p>Lowers full-year 2022 loss per share estimate to $5.72 and 2023 to $4.45 per share.</p>\n<p>\"Consensus is yet to factor in rising losses in the medium term based on expansion into new markets in Europe/India.\"</p>\n<p>The Neutral rating agrees theNeutral Quant Rating, with the best factor grade in Momentum and the worst in Valuation.</p>\n<p>However, the Neutral rating diverges from the Very BullishWall Street Analyst Rating(18 Very Bullish, 7 Bullish).</p>\n<p>Previously, (June 10) Sea gotupgraded to Buy at BofA.</p>\n<p><img src=\"https://static.tigerbbs.com/6013b61a037fd78ec0a89cb8d3193ddc\" tg-width=\"726\" tg-height=\"279\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SE":"Sea Ltd"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1191602151","content_text":"Sea shares fell more than 7% after cut to Neutral at BofA on slowing growth.\n\nBank of America analyst Sachin Salgaonkar downgrades the stock to a Neutral rating from a Buy.\nIn addition, Sea kept gaming guidance unchanged, which implies slowing growth in Q4, Salgaonkar writes in a note to clients.\nThe analyst sees a balanced risk/reward for the stock; shares climb 85% Y/Y.\n\"We cut our gaming revenue estimates to factor in a slowdown and increase e-com losses as we factor increasing cash-burn,\" the analyst notes.\nLowers full-year 2022 loss per share estimate to $5.72 and 2023 to $4.45 per share.\n\"Consensus is yet to factor in rising losses in the medium term based on expansion into new markets in Europe/India.\"\nThe Neutral rating agrees theNeutral Quant Rating, with the best factor grade in Momentum and the worst in Valuation.\nHowever, the Neutral rating diverges from the Very BullishWall Street Analyst Rating(18 Very Bullish, 7 Bullish).\nPreviously, (June 10) Sea gotupgraded to Buy at BofA.","news_type":1,"symbols_score_info":{"SE":0.9}},"isVote":1,"tweetType":1,"viewCount":1723,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879950506,"gmtCreate":1636678186088,"gmtModify":1636678186503,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"Slow but sure","listText":"Slow but sure","text":"Slow but sure","images":[{"img":"https://static.tigerbbs.com/e52eefd34005572c21b56f1d61e84416","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879950506","isVote":1,"tweetType":1,"viewCount":1810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":847953953,"gmtCreate":1636474166866,"gmtModify":1636474167230,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"As long as they filed sec, its not illegal. Honestly, they also think tesla is overvalued","listText":"As long as they filed sec, its not illegal. Honestly, they also think tesla is overvalued","text":"As long as they filed sec, its not illegal. Honestly, they also think tesla is overvalued","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/847953953","repostId":"1127189501","repostType":2,"isVote":1,"tweetType":1,"viewCount":2007,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844447839,"gmtCreate":1636455410265,"gmtModify":1636455410730,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IVDA\">$Iveda Solutions, Inc.(IVDA)$</a>Up only","listText":"<a href=\"https://laohu8.com/S/IVDA\">$Iveda Solutions, Inc.(IVDA)$</a>Up only","text":"$Iveda Solutions, Inc.(IVDA)$Up only","images":[{"img":"https://static.tigerbbs.com/bda88f3189c5fd0ed8a4f10f2f8daefb","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844447839","isVote":1,"tweetType":1,"viewCount":1578,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":845392318,"gmtCreate":1636278122906,"gmtModify":1636278123298,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BKNG\">$Booking Holdings(BKNG)$</a>This has been on meteoric rise. Once gantry all open, price goes up another 30%","listText":"<a href=\"https://laohu8.com/S/BKNG\">$Booking Holdings(BKNG)$</a>This has been on meteoric rise. Once gantry all open, price goes up another 30%","text":"$Booking Holdings(BKNG)$This has been on meteoric rise. Once gantry all open, price goes up another 30%","images":[{"img":"https://static.tigerbbs.com/11541445d326f24f9a97852cc9c2ff40","width":"1125","height":"3463"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/845392318","isVote":1,"tweetType":1,"viewCount":1649,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":841828036,"gmtCreate":1635902291749,"gmtModify":1635902291866,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/IVDA\">$Iveda Solutions, Inc.(IVDA)$</a>slow and sure","listText":"<a href=\"https://laohu8.com/S/IVDA\">$Iveda Solutions, Inc.(IVDA)$</a>slow and sure","text":"$Iveda Solutions, Inc.(IVDA)$slow and sure","images":[{"img":"https://static.tigerbbs.com/246670e66a2812ef5bb140ace806b7e1","width":"1284","height":"2538"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841828036","isVote":1,"tweetType":1,"viewCount":1854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":859297292,"gmtCreate":1634697936966,"gmtModify":1634697998804,"author":{"id":"3574715322913604","authorId":"3574715322913604","name":"WengYongLi","avatar":"https://static.tigerbbs.com/47bde0946b4de3845bcba22c002e0cfd","crmLevel":8,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3574715322913604","authorIdStr":"3574715322913604"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/4DS.AU\">$4DS Memory(4DS.AU)$</a>Hidden and suspended","listText":"<a href=\"https://laohu8.com/S/4DS.AU\">$4DS Memory(4DS.AU)$</a>Hidden and suspended","text":"$4DS Memory(4DS.AU)$Hidden and suspended","images":[{"img":"https://static.tigerbbs.com/067201907e9d120e1588dcf17e2a73db","width":"1242","height":"1767"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/859297292","isVote":1,"tweetType":1,"viewCount":1600,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}